| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |